295 related articles for article (PubMed ID: 36227753)
1. Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort.
Ma E; Ai J; Zhang Y; Zheng J; Gao X; Xu J; Yin H; Fu Z; Xing H; Li L; Sun L; Huang H; Zhang Q; Xu L; Jin Y; Chen R; Lv G; Zhu Z; Zhang W; Wang Z
Emerg Microbes Infect; 2022 Dec; 11(1):2636-2644. PubMed ID: 36227753
[No Abstract] [Full Text] [Related]
2. Evaluation of the effectiveness and safety of sequential vaccination with inactivated SARS-CoV-2 vaccine and Ad5-nCoV booster in pediatric liver transplant recipients.
Zheng Z; Wu H; Sun X; Lu Y; Song Y; Luo Y; Zhou T; Feng M; Wan P; Zhu J; Shen N; Cao Q; Liang J; Xia Q; Xue F
J Med Virol; 2024 Mar; 96(3):e29543. PubMed ID: 38528839
[TBL] [Abstract][Full Text] [Related]
3. Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China.
Yang P; Dang B; Kang W; Li X; Wang T; Li R; Peng M; Liu Y; Wang L; Cheng Y; Yu S; Wei M; Gao H; Kang W; Shang L
Front Public Health; 2023; 11():1107343. PubMed ID: 36960364
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of COVID-19 vaccine immunization during pregnancy in 1024 pregnant women infected with the SARS-CoV-2 Omicron virus in Shanghai, China.
Deng H; Jin Y; Sheng M; Liu M; Shen J; Qian W; Zou G; Liao Y; Liu T; Ling Y; Fan X
Front Immunol; 2023; 14():1303058. PubMed ID: 38292486
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
6. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
Cao Z; Zhang C; Zhao S; Sheng Z; Xiang X; Li R; Qian Z; Wang Y; Chen B; Li Z; Liu Y; An B; Zhou H; Cai W; Wang H; Gui H; Xin H; Xie Q
Infect Dis Poverty; 2022 May; 11(1):56. PubMed ID: 35578350
[TBL] [Abstract][Full Text] [Related]
8. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study.
Tang L; Zhang Y; Wang F; Wu D; Qian ZH; Zhang R; Wang AB; Huang C; Wang H; Ye Y; Lu M; Wang C; Ma YT; Pan J; Li YF; Lv XY; An Z; Rodewald L; Wang XY; Shao YM; Wu ZY; Yin Z
BMJ Open; 2022 Nov; 12(11):e063919. PubMed ID: 36368753
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
Infante MS; Nemirovsky D; Devlin S; DeWolf S; Tamari R; Dahi PB; Lee YJ; Chung DJ; Politikos I; Barker J; Giralt SA; Babady NE; Ramanathan L; Papanicolaou GA; Seo S; Kamboj M; Perales MA; Shah GL
Transplant Cell Ther; 2024 Jan; 30(1):116.e1-116.e12. PubMed ID: 37806446
[TBL] [Abstract][Full Text] [Related]
10. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study.
Wang J; Dong H; Zhao J; Li T; Wang M; Zhou C; Mu H
Front Microbiol; 2023; 14():1096022. PubMed ID: 37065120
[TBL] [Abstract][Full Text] [Related]
11. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
Watson LM
N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
[TBL] [Abstract][Full Text] [Related]
12. Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant.
Wu J; Wei Y; Shen F; Zhu S; Lu Y; Tian X; Zhang P
Front Cell Infect Microbiol; 2022; 12():943407. PubMed ID: 35873164
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
Moon AM; Webb GJ; García-Juárez I; Kulkarni AV; Adali G; Wong DK; Lusina B; Dalekos GN; Masson S; Shore BM; Barnes E; Barritt AS; Marjot T
Hepatol Commun; 2022 Apr; 6(4):889-897. PubMed ID: 34708575
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the COVID-19 vaccination in patients with asymptomatic or mild illness during the Omicron epidemic in Guangzhou: a multi-centre retrospective cohort study.
Xu Y; Kong X; Huang W; Liang Z; Huang J; Li Y; Zhang N; Liu D; Guo W; Mei J
Ann Med; 2024 Dec; 56(1):2307504. PubMed ID: 38465636
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines.
Duan B; Zhang G; Wang W; Yin J; Liu M; Zhang J; Chen D; Ouyang Y; Li G
Front Immunol; 2022; 13():954177. PubMed ID: 36189318
[TBL] [Abstract][Full Text] [Related]
17. Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China.
Gan J; Zhang H; Wu J; Liu Y; Liu P; Cheng R; Tang X; Yang L; Luo W; Li W
J Med Virol; 2024 Feb; 96(2):e29402. PubMed ID: 38380744
[TBL] [Abstract][Full Text] [Related]
18. Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.
Tang Q; Li F; Tian J; Kang J; He J
Clin Exp Med; 2023 Jun; 23(2):457-463. PubMed ID: 35612692
[TBL] [Abstract][Full Text] [Related]
19. Effects of inactivated SARS-CoV-2 vaccination on male fertility: A retrospective cohort study.
Dong Y; Li X; Li Z; Zhu Y; Wei Z; He J; Cheng H; Yang A; Chen F
J Med Virol; 2023 Jan; 95(1):e28329. PubMed ID: 36415120
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
